The most expensive drug in the U.S. is now Lenmeldy, a $4.25 million gene therapy the FDA approved March 18 for children with a rare genetic disease. 

More than half of pharmaceuticals in the United States have a dependency on manufacturers not compliant to the Trade Agreements Act, which the Department of Defense defines as high- and very high-risk medications. 

In 2023, 63% of abortions were performed with abortion pills — an increase from 2020, when the figure was 53%, according to the Guttmacher Institute. 

Pharmaceutical company AstraZeneca plans to acquire biotech company Fusion Pharmaceuticals for up to $2.4 billion, Investopedia reported March 19. 

Unreasonable workload expectations and staffing and scheduling issues ranked highest among negative experiences reported by pharmacy workers in 2023, according to a workplace and well-being report published March 18. 

On March 18, the FDA approved the first gene therapy for children with metachromatic leukodystrophy, a debilitating, rare genetic disease. 

Livonia, Mich.-based Trinity Health is temporarily shuttering its pharmacy on Eastern Michigan University's campus. 

After the FDA questioned the safety of two CAR-T therapies, members of the agency's Oncologic Drugs Advisory Committee voted unanimously to recommend Carvykti, made by Janssen Biotech, and voted 8-3 in favor for Abecma, from Bristol-Myers Squibb K.K.

Detroit-based Henry Ford Health said its centralized pharmacy services center, which opened in September, is designed to save the system $30 million over five years. 

On March 14, the FDA approved the nation's first medication to treat noncirrhotic non-alcoholic steatohepatitis with fibrosis, or fatty liver scarring.